Sweden's Ortivus Q2 net sales fall, gross margin declines
Sweden's Ortivus Q2 net sales fall, gross margin declines
Overview
Sweden healthcare technology provider's Q2 net sales fell 2% yr/yr
Gross margin for Q2 declined to 37% from 51% last year
Company divested shares in H&E Solutions AB, strengthening liquidity
Outlook
Company did not provide specific financial guidance for the current or future periods
Result Drivers
LIQUIDITY BOOST - Sale of H&E Solutions AB shares improved liquidity, with continued collaboration on MobiMed enRoute
PRODUCT DEVELOPMENT - Appointment of new Chief Product Officer and partnership with Tortus AI to advance MobiMed platform
Company press release: ID:nMFNc29kWc
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Net Loss |
| SEK 3.60 mln |
|
Q2 Gross Margin |
| 37.00% |
|
Q2 EBITDA |
| -SEK 2.80 mln |
|
Reuters Recommended Reads
Aug 25 - Sweden's Isofol Medical reports no Q2 revenue, net loss widens
Aug 25 - IT service provider Tialis H1 revenue falls on delayed orders, contract losses
Aug 25 - Sweden's QleanAir Q2 revenue edges up
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)